FormFactor

At the Global TMT Conference 2026, FormFactor presented a target model of $1.6 billion in revenue, a 55% gross margin and $5 earnings per share by 2030, emphasizing that advanced packaging, chiplets, HBM and AI applications will significantly increase test demand. The company reports HBM revenue growth of 60–70% in H1 2026, raised its CPO forecast to $20 million and cited capacity constraints as a short‑term growth limiter; the new site in Farmers Branch, Texas, is expected to ramp up from Q4 2026. FormFactor is pursuing operational improvements rather than price increases to boost margins, sees opportunities in customer‑specific ASICs, GPUs and photonics, but warns of execution risks in ramping fab capacity. » More on de.investing.com

Kelley Steven-Waiss sold 2,100 FormFactor shares on Sept. 3, 2026 at a weighted average price of $96.10, generating about $201,810. The sale represented roughly 8% of his pre-transaction direct holdings; he retains 24,426 shares valued at about $2.3 million post-transaction. The transaction is presented as a routine partial disposition amid a 12-month stock gain of about 284% and continued analyst bullishness (median one-year target $165). » More on finance.yahoo.com

FormFactor has built a leading position in cryogenic test equipment and probe cards for quantum and semiconductor chips, offering dilution refrigerators, high-throughput cryogenic probers and benchtop Flatiron systems to speed qubit validation. Partnerships like the Delft Circuits cabling integration greatly increase channel density, addressing wiring and cooling bottlenecks that limit qubit scale-up. While its quantum products are a small part of a broader semiconductor test business, FormFactor stands to benefit as the industry shifts from lab demos to repeatable manufacturing. » More on finance.yahoo.com